Compare PIII & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PIII | COCH |
|---|---|---|
| Founded | 2015 | 1995 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Nursing Services | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 33.8M | 51.0M |
| IPO Year | 2021 | 2021 |
| Metric | PIII | COCH |
|---|---|---|
| Price | $7.05 | $0.72 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 4 | 2 |
| Target Price | ★ $9.00 | $6.00 |
| AVG Volume (30 Days) | 17.1K | ★ 49.9K |
| Earning Date | 05-14-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 17.45 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,459,080,000.00 | $241,000.00 |
| Revenue This Year | $7.67 | $1.58 |
| Revenue Next Year | $2.36 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 7.11 |
| 52 Week Low | $1.52 | $0.36 |
| 52 Week High | $16.89 | $1.89 |
| Indicator | PIII | COCH |
|---|---|---|
| Relative Strength Index (RSI) | 26.79 | 49.33 |
| Support Level | $2.39 | $0.63 |
| Resistance Level | $11.55 | $0.74 |
| Average True Range (ATR) | 0.43 | 0.03 |
| MACD | -0.08 | 0.00 |
| Stochastic Oscillator | 0.00 | 46.56 |
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all. It includes utilization management, care management, disease education, and maintenance of a quality improvement and quality management program for members assigned to the Company. The Company is also responsible for the credentialing of its providers, processing and payment of claims, and the establishment of a provider network for certain health plans.
Envoy Medical Inc is a hearing health company focused on providing medical technologies across the hearing loss spectrum. Its product portfolio comprises: the Esteem FI-AMEI, a fully implanted active middle ear implant (FI -AMEI) that works with the ear's natural anatomy, and is FDA-approved for adults with moderate to severe sensorineural hearing loss; and Acclaim CI, an investigational cochlear implant under development. The company derives all of its revenue substantially from the sale of the Esteem FI-AMEI implants and their replacement components. It has one reportable segment: hearing.